Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Zenas BioPharma, Inc. (ZBIO) had Weighted-Average Shares Outstanding (Diluted) of 41.80M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$10.00M |
|
$-33.57M |
|
-- |
|
$10.00M |
|
$47.33M |
|
$-37.33M |
|
$3.55M |
|
$-33.78M |
|
$-33.78M |
|
$-33.57M |
|
$-33.57M |
|
$-33.57M |
|
$-33.57M |
|
$-37.33M |
|
$-37.31M |
|
41.80M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
41.80M |
$-0.80 |
|
$-0.80 |
|
| Balance Sheet Financials | |
$317.81M |
|
$0.07M |
|
$15.96M |
|
$333.77M |
|
$49.13M |
|
-- |
|
$0.32M |
|
$49.45M |
|
$284.32M |
|
$284.32M |
|
$284.32M |
|
41.82M |
|
| Cash Flow Statement Financials | |
$-37.05M |
|
$-86.27M |
|
$0.10M |
|
$319.83M |
|
$196.55M |
|
$-123.28M |
|
$5.39M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.47 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-373.30% |
|
-373.30% |
|
-- |
|
-337.78% |
|
-335.73% |
|
$-37.07M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
-- |
|
-- |
|
-11.81% |
|
-11.81% |
|
-10.06% |
|
-11.81% |
|
$6.80 |
|
$-0.89 |
|
$-0.89 |
|